首页> 外文期刊>Journal of Thoracic Disease >Initial experience of single-port video-assisted thoracoscopic surgery sleeve lobectomy and systematic mediastinal lymphadenectomy for non-small-cell lung cancer
【24h】

Initial experience of single-port video-assisted thoracoscopic surgery sleeve lobectomy and systematic mediastinal lymphadenectomy for non-small-cell lung cancer

机译:单端口电视胸腔镜手术袖式肺叶切除术和系统性纵隔淋巴结清扫术治疗非小细胞肺癌的初步经验

获取原文
           

摘要

Background: In this study, we evaluate the feasibility and safety of single-port video-assisted thoracoscopic surgery (VATS) sleeve lobectomy (SL) and systematic mediastinal lymphadenectomy and summarize our surgical experience. Methods: From October 2014 to December 2015, eight cases of single-port VATS SL [seven male patients and one female patient, median age 56.0 (range, 38–63) years] were performed by a single group of surgeons in Fujian Medical University Fujian Union Hospital. The median tumor size was 2.7 cm. Types of resection included four right upper, one right lower, and three left upper sleeve lobectomies. Systematic mediastinal lymphadenectomy was performed in all patients. A modified anastomosis technique developed by the author (Chen’s technique) was applied for bronchial anastomosis. Postoperative outcome and short-term follow-up data were recorded and analyzed. Results: All eight operations were completed uneventfully with no conversion to thoracotomy or reoperation required. No perioperative death was observed. Major results (medians or percentages) were as follows: operative duration, 234.5 [185–345] min; bronchial anastomosis duration, 38.0 [30–43] min; blood loss, 65.0 [50–200] mL; number of lymph node dissected, 22.5 [18–37]. The postoperative complication rate was 37.5% (three of eight cases, including two pulmonary infections and one atrial fibrillation). All patients recovered and were discharged uneventfully with symptomatic therapy. Pathology showed squamous cell carcinoma in seven patients and adenocarcinoma in one patient; two patients were in TNM stage IB, three in stage IIA, one in stage IIB, and two in stage IIIA. The mean follow-up was 7.5 [2–15] months. There were no tumor recurrences or bronchial anastomotic complications. Conclusions: Single-port VATS SL and mediastinal lymphadenectomy are safe and feasible. Improvements in operating procedures can help facilitate single-port VATS. The application of Chen’s technique in bronchial anastomosis is easy and reliable and shows a satisfactory short-term clinical outcome.
机译:背景:在这项研究中,我们评估了单端口电视胸腔镜手术(VATS)袖状叶切除术(SL)和系统纵隔淋巴结清扫术的可行性和安全性,并总结了我们的手术经验。方法:2014年10月至2015年12月,由福建医科大学医学院的单组外科医生进行了8例单口VATS SL [男7例,女1例,中位年龄56.0(范围:38-63)岁]的研究。福建协和医院。中位肿瘤大小为2.7厘米。切除的类型包括四个右上,一个右下和三个左上袖肺叶切除术。所有患者均行系统性纵隔淋巴结清扫术。作者开发的一种改良的吻合技术(Chen的技术)被应用于支气管吻合术。记录并分析术后结果和短期随访数据。结果:所有八项手术均顺利完成,无需转换为开胸手术或再次手术。没有观察到围手术期死亡。主要结果(中位数或百分比)如下:手术时间234.5 [185–345]分钟;支气管吻合持续时间38.0 [30–43]分钟;失血量为65.0 [50–200] mL;解剖的淋巴结数目为22.5 [18-37]。术后并发症发生率为37.5%(8例,其中2例肺部感染和1例房颤)。所有患者均康复,并通过对症治疗顺利出院。病理显示鳞状细胞癌7例,腺癌1例。两名患者处于TNM IB期,三名处于IIA期,一名处于IIB期,两名在IIIA期。平均随访时间为7.5 [2-15]个月。没有肿瘤复发或支气管吻合并发症。结论:单端口VATS SL和纵隔淋巴结清扫术是安全可行的。改进操作程序可以帮助简化单端口VATS。陈氏技术在支气管吻合术中的应用简便可靠,并显示出令人满意的短期临床效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号